Patents by Inventor Philip Gregory

Philip Gregory has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080118469
    Abstract: Disclosed herein are methods and compositions for treatment of conditions requiring inhibition of angiogenesis. Such conditions include those characterized by neovascularization, such as retinopathies, macular degeneration and various malignancies.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 22, 2008
    Inventors: H. Zhang, Philip Gregory
  • Publication number: 20080108556
    Abstract: Disclosed herein are methods and compositions for treatment of conditions requiring inhibition of angiogenesis. Such conditions include those characterized by neovascularization, such as retinopathies, macular degeneration and various malignancies.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 8, 2008
    Inventors: H. Zhang, Philip Gregory
  • Publication number: 20070134796
    Abstract: Disclosed herein are methods and compositions for targeted integration of a exogenous sequence into a predetermined target site in a genome for use, for example, in protein expression and gene inactivation.
    Type: Application
    Filed: July 26, 2006
    Publication date: June 14, 2007
    Inventors: Michael Holmes, Fyodor Urnov, Philip Gregory, Edward Rebar, Sean Brennan
  • Patent number: 7220719
    Abstract: Disclosed herein are methods and compositions for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.
    Type: Grant
    Filed: May 13, 2004
    Date of Patent: May 22, 2007
    Assignee: Sangamo Biosciences, Inc.
    Inventors: Casey C. Case, Elizabeth Wolffe, legal representative, Fyodor Urnov, Albert Lai, Andrew Snowden, Siyuan Tan, Philip Gregory, Alan Wolffe, deceased
  • Publication number: 20060210539
    Abstract: Disclosed herein are methods and compositions for treatment of conditions requiring inhibition of angiogenesis. Such conditions include those characterized by neovascularization, such as retinopathies, macular degeneration and various malignancies.
    Type: Application
    Filed: February 28, 2006
    Publication date: September 21, 2006
    Inventors: H. Zhang, Philip Gregory
  • Patent number: 6933113
    Abstract: Disclosed herein are methods and compositions for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.
    Type: Grant
    Filed: August 28, 2001
    Date of Patent: August 23, 2005
    Assignee: Sangamo BioSciences, Inc.
    Inventors: Casey C. Case, Elizabeth Wolffe, Fyodor Urnov, Albert Lai, Andrew Snowden, Siyuan Tan, Philip Gregory, Alan Wolffe
  • Publication number: 20040204345
    Abstract: Disclosed herein are methods and compositions for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.
    Type: Application
    Filed: May 13, 2004
    Publication date: October 14, 2004
    Applicant: Sangamo Biosciences, Inc.
    Inventors: Casey C. Case, Alan Wolffe, Elizabeth J. Wolffe, Fyodor Urnov, Albert Lai, Andrew Snowden, Siyuan Tan, Philip Gregory
  • Publication number: 20020160940
    Abstract: Disclosed herein are methods and compositions for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.
    Type: Application
    Filed: August 28, 2001
    Publication date: October 31, 2002
    Inventors: Casey C. Case, Alan Wolffe, Fyodor Urnov, Albert Lai, Andrew Snowden, Siyuan Tan, Philip Gregory